Argent BioPharma Limited

CHIA:RGT Stock Report

Market Cap: AU$13.0m

Argent BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

CHIA:RGT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Oct 24BuyAU$1,640,001Roby ZomerIndividual4,000,000AU$0.41
10 Sep 24BuyAU$503,399Roby ZomerIndividual1,258,500AU$0.40

Insider Trading Volume

Insider Buying: RGT insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of RGT?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,170,4392.16%
Private Companies9,629,21817.7%
Individual Insiders12,935,14023.8%
General Public30,537,47256.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 53.2%.


Top Shareholders

Top 9 shareholders own 43.73% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.1%
Roby Zomer
9,292,320AU$2.2m619%no data
15.4%
Oak Capital Partners Llc
8,370,718AU$2.0m0%no data
3.56%
Shachar Shimony
1,933,000AU$463.9k2,680%no data
2.32%
Bioheka Limited
1,258,500AU$302.0k1,080%no data
2.06%
Yifat Steuer
1,117,194AU$268.1k-93.9%no data
1.83%
Spreadex.com Limited, Asset Management Arm
993,953AU$238.5k0%0.55%
1.09%
Amir Polak
592,626AU$142.2k0%no data
0.32%
Premier Fund Managers Ltd.
176,203AU$42.3k0%no data
0.00052%
Barclays PLC Private Banking & Investment Banking Investment
283AU$67.70%no data